NCT01223248
Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy
At risk: Primary completion moved at least 11 months later.
See at-risk trials from Memorial Sloan Kettering Cancer Center
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 41 versions: 32 with changes below, 9 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Oct 2026 to Oct 2027
- Eligibility criteria expanded, about 20 words
- Secondary endpoints: details revised at 1 of 4 entries
- Publications: details revised at 2 of 2 entries
- Notable Primary and study completion dates: Oct 2025 to Oct 2026v40
- Notable Primary and study completion dates: Oct 2024 to Oct 2025v39
- Notable Primary and study completion dates: Oct 2023 to Oct 2024v37
- Notable Primary and study completion dates: Oct 2022 to Oct 2023v36
Show 26 earlier versionsHide 26 earlier versions
- Notable Primary and study completion dates: Oct 2021 to Oct 2022v35
- Notable Primary and study completion dates: Oct 2020 to Oct 2021v34
- Notable Primary and study completion dates: Oct 2019 to Oct 2020v32
- Notable Primary and study completion dates: Oct 2018 to Oct 2019v31
- Notable Primary and study completion dates: Oct 2017 to Oct 2018
- Site details revised at 1 of 4 sites
- Notable Primary and study completion dates: Oct 2016 to Oct 2017
- Trial status: Recruiting to Active, Not Recruiting
- Enrollment target: estimated 300 to confirmed 220
- Site details revised at 4 of 4 sites
- Minor Site details revised at 1 of 4 sitesv27
- Minor Site details revised at 2 of 4 sitesv26
- Minor Site details revised at 1 of 4 sitesv25
- Notable Trial status: Suspended to Recruiting
- Enrollment target: 200 to 300
- Site details revised at 4 of 4 sites
- Stopped Trial status: Recruiting to Suspended
- Primary and study completion dates: Oct 2015 to Oct 2016
- Site details revised at 4 of 4 sites
- Minor Study sites revised (4)v21
- Minor Site details revised at 1 of 4 sitesv19
- Notable Primary and study completion dates: Oct 2014 to Oct 2015
- Site details revised at 1 of 4 sites
- Notable Eligibility criteria expanded, about 1 word
- Study sites: 3 to 4
- Collaborators: 2 to 3
- Notable Trial status: Suspended to Recruiting
- Site details revised at 3 of 3 sites
- Stopped Trial status: Recruiting to Suspended
- Site details revised at 3 of 3 sites
- Notable Primary and study completion dates: Oct 2013 to Oct 2014
- Site details revised at 1 of 3 sites
- Notable Eligibility criteria shortened, about 21 wordsv12
- Notable Enrollment target: 100 to 200
- Eligibility criteria expanded, about 1 word
- Study sites: 2 to 3
- Collaborators: 1 to 2
- Notable Primary and study completion dates: Oct 2012 to Oct 2013
- Eligibility criteria revised
- Secondary endpoints: 3 to 4
- Notable Eligibility criteria expanded, about 4 wordsv6
- Notable Eligibility criteria expanded, about 35 words
- Secondary endpoints: 2 to 3
- Notable Eligibility criteria expanded, about 49 wordsv4
- Notable Eligibility criteria expanded, about 14 wordsv3
- Minor Study sites: 1 to 2v2
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (4)
Arms and interventions
This is a phase III, multicenter, randomized, study comparing two dosing schedules for hypofractionated image-guided radiation therapy to bone, spine, soft tissue, and lymph nodes in patients with metastatic disease
This is a phase III, multicenter, randomized, study comparing two dosing schedules for hypofractionated image-guided radiation therapy to bone, spine, soft tissue, and lymph nodes in patients with metastatic disease
Radiation: IGIMRT using a single dose of 24 Gy, IGIMRT 27 Gy in 3 fractions
Sites
4 sites in 3 countries
United States 2, Italy 1, Portugal 1